Inflexion has sold its investment in Newbury-based Kynetec, a leader in agricultural and animal health market research, data and insights, to US-based Paine Schwartz Partners. The transaction follows a nearly five-year partnership.
Simon Turner, Managing Partner at Inflexion, said: “We are proud to have built the global leader in agricultural and animal health information alongside an incredibly ambitious management team. During our partnership, Kynetec has seen significant acquisitive growth in both the UK and internationally and we look forward to seeing the business continue to prosper.”
Kevin Schwartz, Chief Executive Officer of Paine Schwartz, said: “We are investing in Kynetec at a time when the use of data and the ability to analyze it is becoming more critical as companies across the value chain increasingly rely on it to implement efficient and sustainable practices. With its global footprint, best- in-class offerings and a blue-chip customer base, Kynetec has a strong foundation and the ability to grow by moving to new markets, deepening its offerings, enhancing its technology and pursuing complementary bolt-on acquisitions. In particular, key opportunities include expanding in the machinery segment, growing animal health offerings and delivering solutions that support agricultural sustainability. We are excited to work with Daniel and the rest of the Kynetec team to translate their ability to quantify farming practices into sustainability-oriented products and capture opportunities across the Company’s large and growing addressable market.”